Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Oelke

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Frontiers in Medicine|January 9, 2023
AIM™ platform: A new immunotherapy approach for viral diseasesDavid Langan, Ruipeng Wang, Keshanti Tidwell, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Nanoscale artificial antigen presenting cells for T cell immunotherapyKarlo Perica, Andrés De León Medero, Malarvizhi Durai, et al.
Blood Immunology & Cellular Therapy|July 7, 2025
Combining antigen specific T-cells with T-cell engager therapy induces a molecular signature that favors T-cell fitnessManpreet Bariana, Sidharth Anand, Mark Batistick, et al.
ACS Nano|July 15, 2015
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive ImmunotherapyKarlo Perica, Joan Glick Bieler, Christian Schütz, et al.
Plos Neglected Tropical Diseases|February 6, 2013
T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsAndréa Barbosa de Melo, Eduardo J M Nascimento, Ulisses Braga-Neto, et al.
Neoplasia (New York, N.Y.)|April 14, 2026
PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapyHong Lou, David Langan, Nick Syracuse, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapyHong Lou, David Langan, Nick Syracuse, et al.
The Journal of Clinical Investigation|December 3, 2013
Sprouty-2 regulates HIV-specific T cell polyfunctionalityYen-Ling Chiu, Liang Shan, Hailiang Huang, et al.
The Journal of Infectious Diseases|April 2, 2015
Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older AdultsKevin Najarro, Huy Nguyen, Guobing Chen, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Frontiers in Medicine|January 9, 2023
AIM™ platform: A new immunotherapy approach for viral diseasesDavid Langan, Ruipeng Wang, Keshanti Tidwell, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 30, 2013
Nanoscale artificial antigen presenting cells for T cell immunotherapyKarlo Perica, Andrés De León Medero, Malarvizhi Durai, et al.
Blood Immunology & Cellular Therapy|July 7, 2025
Combining antigen specific T-cells with T-cell engager therapy induces a molecular signature that favors T-cell fitnessManpreet Bariana, Sidharth Anand, Mark Batistick, et al.
ACS Nano|July 15, 2015
Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive ImmunotherapyKarlo Perica, Joan Glick Bieler, Christian Schütz, et al.
Plos Neglected Tropical Diseases|February 6, 2013
T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsAndréa Barbosa de Melo, Eduardo J M Nascimento, Ulisses Braga-Neto, et al.
Neoplasia (New York, N.Y.)|April 14, 2026
PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapyHong Lou, David Langan, Nick Syracuse, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapyHong Lou, David Langan, Nick Syracuse, et al.
The Journal of Clinical Investigation|December 3, 2013
Sprouty-2 regulates HIV-specific T cell polyfunctionalityYen-Ling Chiu, Liang Shan, Hailiang Huang, et al.
The Journal of Infectious Diseases|April 2, 2015
Telomere Length as an Indicator of the Robustness of B- and T-Cell Response to Influenza in Older AdultsKevin Najarro, Huy Nguyen, Guobing Chen, et al.
Pageof 5